Emergence of Cumyl-PEGACLONE-related fatalities in the Northern Territory of Australia

Characteristics and circumstances of synthetic cannabinoid-related death

Shane Darke, Johan Duflou, Michael Farrell et al. · Clinical Toxicology · 2019 · 94 citations

Pharmacy, Clinical Toxicology, Toxicology +14

Four cases of death involving the novel synthetic cannabinoid 5F-Cumyl-PEGACLONE

Arianna Giorgetti, Lukas Mogler, Sebastian Halter et al. · Forensic Toxicology · 2019 · 35 citations · Full text

Pharmacy, Pharmacology, Toxicology +15

A Fatality Involving Furanylfentanyl and MMMP, with Presumptive Identification of Three MMMP Metabolites in Urine

Christine Nash, Danielle M. Butzbach, Peter Stockham et al. · Journal of Analytical Toxicology · 2018 · 28 citations

Pharmacy, Pharmacology, Toxicology +15

<i>In vitro</i> activity profiling of Cumyl‐PEGACLONE variants at the CB₁ receptor: Fluorination <i>versus</i> isomer exploration

Liesl K. Janssens, Annelies Cannaert, Matthew Connolly et al. · Drug Testing and Analysis · 2020 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Identification of a thermal degradation product of CUMYL‐PEGACLONE and its detection in biological samples

Christine Nash, Linda Glowacki, Dimitri Gerostamoulos et al. · Drug Testing and Analysis · 2019 · 13 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16